<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>JCAD &#187; 04-2009 (April 2009)</title>
	<atom:link href="http://www.jcadonline.com/category/issue-archives/04-2009-april-2009/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.jcadonline.com</link>
	<description>The Journal of Clinical and Aesthetic Dermatology (JCAD)</description>
	<lastBuildDate>Mon, 19 Jul 2010 21:02:58 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0</generator>
		<item>
		<title>Safety and Efficacy of Multiple 16-week Courses of Topical Imiquimod for the Treatment of Large Areas of Skin Involved with Actinic Keratoses</title>
		<link>http://www.jcadonline.com/safety-and-efficacy-of-multiple-16-week-courses-of-topical-imiquimod-for-the-treatment-of-large-areas-of-skin-involved-with-actinic-keratoses/</link>
		<comments>http://www.jcadonline.com/safety-and-efficacy-of-multiple-16-week-courses-of-topical-imiquimod-for-the-treatment-of-large-areas-of-skin-involved-with-actinic-keratoses/#comments</comments>
		<pubDate>Fri, 17 Apr 2009 13:36:41 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[04-2009 (April 2009)]]></category>
		<category><![CDATA[Actinic Keratoses]]></category>
		<category><![CDATA[Original Research]]></category>

		<guid isPermaLink="false">http://www.jcadonline.com/?p=1221</guid>
		<description><![CDATA[James Q. Del Rosso, DO, FAOCD; Valley Hospital Medical Center, Las Vegas, Nevada Howard Sofen, MD; Dermatology Associates, Los Angeles, California; Barry Leshin, MD; The Skin Surgery Center, Winston-Salem, North Carolina TC Meng, MD; James Kulp, BS and Sharon Levy, MD, Graceway Pharmaceuticals, Bristol, Tennessee Disclosure: Dr. Del Rosso is a consultant, researcher, and speaker [...]]]></description>
		<wfw:commentRss>http://www.jcadonline.com/safety-and-efficacy-of-multiple-16-week-courses-of-topical-imiquimod-for-the-treatment-of-large-areas-of-skin-involved-with-actinic-keratoses/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
